Ifp Advisors, Inc Rubius Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$17.6 - $25.91 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$22.26 - $28.43 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$8.02 - $32.01 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$4.23 - $8.73 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$4.65 - $6.25 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$4.01 - $6.88 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$3.74 - $9.84 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$7.23 - $14.12 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$7.85 - $15.75 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	SELL	$13.27 - $18.51 $1,327 - $1,851	-100 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$13.83 - $22.97 $9,390 - $15,596	-679 Reduced 87.16%	100 $1,000
Q3 2018 Oct 25, 2018	BUY	$20.06 - $26.94 $15,626 - $20,986	779 New	779 $0

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.